Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
about
Cancer diagnostic classifiers based on quantitative DNA methylationMethylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancerHypermethylation of EDNRB promoter contributes to the risk of colorectal cancer.TGF-β mediated DNA methylation in prostate cancer.Batch effect correction for genome-wide methylation data with Illumina Infinium platform.Interrogating genomic and epigenomic data to understand prostate cancerDNA methylation gene-based models indicating independent poor outcome in prostate cancer.Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.A DNA methylation classifier of cervical precancer based on human papillomavirus and human genesEpigenetic susceptibility factors for prostate cancer with aging.RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysisComparative studies of the composition of bacterial microbiota associated with the ruminal content, ruminal epithelium and in the faeces of lactating dairy cowsCharacterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer.Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer.HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populationsNKAIN2 functions as a novel tumor suppressor in prostate cancer.A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancersCredentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.Early progress in epigenetic regulation of endothelin pathway genes.APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.Prognostic DNA methylation markers for prostate cancer.The Promise and the Problems of Epigenetics Biomarkers in Cancer.Aberrant gene-specific DNA methylation signature analysis in cervical cancer.Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.Identification of ZDHHC14 as a novel human tumour suppressor gene.Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions.Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.A concordance index for matched case-control studies with applications in cancer risk.The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.
P2860
Q27012960-9EF11AD9-4B85-48F1-8E80-7C5B45F69390Q30764223-A7680A6D-CC2B-4134-AF6B-884023B0F959Q33645099-148BE053-5BEC-48BC-89D6-F42112994BD6Q34039935-96C6D89C-68B0-46B0-97DF-D5634204FACDQ34101704-DFEC1ED1-7426-4B92-B402-305F0236E79CQ34125866-3C3FB84E-2109-4ADC-B332-40046D0B9D62Q34174356-4F8CB74C-C03F-46A0-AA7E-D1B66453F001Q34465132-90CD271C-1FB3-4557-9ED7-C929850F92E8Q34531028-84C3FD32-F8F3-4558-B189-A39A858BFCBBQ34541756-813F0E4D-8B5B-49F3-9D72-48170455C17AQ34558896-BD26C9CA-B00D-43C2-BBCB-C3B124B02309Q35000853-C492E0FE-B34C-45FB-9518-A7A60A8C0D20Q35096197-7F7BAE43-70F8-4227-BE14-6211E6E26811Q35212069-A89330BC-53F7-4CEA-97FA-82EE32720938Q35832904-1727C5E9-D4C9-446D-99EC-554A6947D118Q35852010-713CE27C-F983-48D3-A8DA-A8335030B194Q35911453-84BD9E05-16E9-4BF2-B1AB-2EF70590A739Q36341102-FF7206DC-A313-44B2-B8D6-E14113647078Q36385102-37D1413B-135C-4F04-9167-39BA7A24D6FBQ36396570-97E5289A-5A0F-4025-8A67-9F1F676D963DQ36609819-31D7C871-DFF4-46EB-87B0-05EB00D70009Q36705589-14E74FB1-98F6-412A-88EE-1B3677193755Q36774335-1660C745-5CD3-4116-84DB-380403EE9AAFQ37001814-A5996A91-0FFA-4985-99EC-29270E73C2D9Q37144743-31DEB409-92F6-4886-8EE1-AA4631B1412EQ37665477-8B92AAEC-65C3-4B44-92ED-A2DC07CE8E2BQ37671558-63F0AA98-3C3B-4CE9-9D1E-CB65D0E9A1F5Q37706679-A7C84A04-5BD2-41C7-A31E-B6512B6064C1Q37973381-D539B056-14DE-4679-9361-E7AE03285F87Q38072660-40D3CA7B-516E-4B9F-9331-883C752505BDQ38252624-85823F58-F510-4774-BEE4-C13E892A77BFQ38681923-4E375A41-9062-43F1-9793-4175DC1A6522Q38870688-681C104A-11EA-401E-8C3D-C001D3EB06ECQ38917215-7CB923A7-C16F-485B-81CF-18661C32986DQ39020172-F9F20AB1-30F7-4633-9769-717118DC8810Q39035797-D9781142-7790-4C8E-B8A9-3ED4440259CDQ41612137-5349FD47-FFF8-41DE-9CD1-5D06EB77CAD9Q42804809-499AD52E-EEC5-4347-9ADF-66EE8CCE8F52Q44325877-228CA3D9-7291-44BD-B001-F17268355908Q44538170-8F91AC80-266D-4E7B-B027-AB341A70AA32
P2860
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Absolute quantitation of DNA m ...... e cancer using pyrosequencing.
@en
type
label
Absolute quantitation of DNA m ...... e cancer using pyrosequencing.
@en
prefLabel
Absolute quantitation of DNA m ...... e cancer using pyrosequencing.
@en
P2093
P50
P1433
P1476
Absolute quantitation of DNA m ...... te cancer using pyrosequencing
@en
P2093
Attila T Lorincz
Dae Cheol Kim
Greg L Shaw
Jack Cuzick
Keqiang Wu
Luis Beltran
Nataša Vasiljević
Sakunthala C Kudahetti
Xueying Mao
P304
P356
10.1155/2011/157829
10.3233/DMA-2011-0790
P577
2011-01-01T00:00:00Z